Legend Biotech SG&A Expense (Quarterly) Trends

Legend Biotech Corp (LEGN)

45.41 -0.52 (-1.13%) USD | NASDAQ | May 03, 16:00

45.42 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	62.38M
September 30, 2023	49.20M
June 30, 2023	49.18M
March 31, 2023	40.16M
December 31, 2022	52.50M
September 30, 2022	42.10M
June 30, 2022	45.49M
March 31, 2022	33.96M
December 31, 2021	69.98M
September 30, 2021	31.34M

Date	Value
June 30, 2021	26.01M
March 31, 2021	22.18M
December 31, 2020	33.34M
September 30, 2020	15.32M
June 30, 2020	14.06M
March 31, 2020	9.975M
December 31, 2019	15.42M
September 30, 2019	6.452M
June 30, 2019	6.637M
March 31, 2019	3.861M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

6.452M

Minimum

Sep 2019

69.98M

Maximum

Dec 2021

32.93M

Average

33.34M

Median

Dec 2020

SG&A Expense (Quarterly) Benchmarks